Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
120Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0.00 | $8.50M | $0.85 |
| 2024 | $0.00 | $2.43M | $0.24 |
| 2023 | $0.00 | $-4.9K | $-0.50 |
| 2022 | $0.00 | $-10.25M | $-1.03 |
| 2021 | $0.00 | $1.24M | $0.13 |
Social Signal Score
Earnings
Thu, Nov 12(in 3 months)
Consensus estimate $0.21 per share
Typical surprise +124.3% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Aug 13$1.31 vs $0.19beat
- Thu, May 14$0.16 vs $0.17miss
- Wed, Feb 18$0.44 vs $0.18beat
- Thu, Nov 13$0.60 vs $0.10beat
- Wed, Aug 13$0.19 vs $0.09beat
- Wed, May 14$0.09 vs $0.06beat
Estimates and results for KPTSF via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
Project earnings forward and see what return today's price implies.
Seeded from KPTSF's reported EPS growth of 59.9% a year over 4 years. Historical EPS growth of 60% reflects a recovery from a low base and won't persist. Capped at 30% as a starting point.
- EPS in 5 years
- $3.16
- Implied price
- $37.88
- Return from $9.14
- 32.9% a year
To earn 15.0% a year on these assumptions you'd need to buy at $18.83 — today's price is already 51.5% below that.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 8 | 10 | 12 | 14 | 16 |
|---|---|---|---|---|---|
| 20.0% | 13.1% | 18.3% | 22.7% | 26.5% | 29.9% |
| 25.0% | 17.8% | 23.2% | 27.8% | 31.8% | 35.3% |
| 30.0% | 22.5% | 28.1% | 32.9% | 37.0% | 40.8% |
| 35.0% | 27.3% | 33.1% | 38.0% | 42.3% | 46.2% |
| 40.0% | 32.0% | 38.0% | 43.1% | 47.6% | 51.6% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Mentions (1)
- Newsmarketbeat.com·1d ago·Positive
KP Tissue Q2 Earnings Call Highlights KP Tissue TSE: KPT reported higher second-quarter revenue and adjusted EBITDA, supported by stronger U.S. sales volumes, improved performance at its Memphis facility and lower pulp prices. Management said it expects third-quarter adjusted EBITDA to remain in line with the CAD 90.6 million generated in the second quarter.
View source ↗